These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Left ventricular hypertrophy and cardiovascular risk in hypertension]. Amabile G Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934 [TBL] [Abstract][Full Text] [Related]
4. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment. Agabiti-Rosei E Blood Press Suppl; 1997; 2():13-5. PubMed ID: 9495620 [TBL] [Abstract][Full Text] [Related]
5. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study. Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193 [No Abstract] [Full Text] [Related]
6. [Arterial hypertension, left ventricular hypertrophy and antihypertensive treatment]. de la Figuera M Aten Primaria; 1995 Apr; 15(6):339-40. PubMed ID: 7749022 [No Abstract] [Full Text] [Related]
7. Hypertensive heart disease--significance of left ventricular hypertrophy. Schmieder RE J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190 [TBL] [Abstract][Full Text] [Related]
8. Hypertension and left ventricular hypertrophy: what is the link? Arthur A; McNulty CM R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500 [No Abstract] [Full Text] [Related]
9. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Pierdomenico SD; Lapenna D; Cuccurullo F Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364 [TBL] [Abstract][Full Text] [Related]
10. Is left ventricular hypertrophy regression important? Does the tool used to detect it matter? Nadour W; Biederman RW J Clin Hypertens (Greenwich); 2009 Aug; 11(8):441-7. PubMed ID: 19695032 [TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular hypertrophy in hypertension--does it reduce cardiovascular risk? Braz Nogueira J Rev Port Cardiol; 2005; 24(7-8):1007-13. PubMed ID: 16240686 [TBL] [Abstract][Full Text] [Related]
12. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population. Cuspidi C; Facchetti R; Bombelli M; Sala C; Grassi G; Mancia G J Hypertens; 2014 Apr; 32(4):921-8. PubMed ID: 24406778 [TBL] [Abstract][Full Text] [Related]
14. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension. Clement DL; De Buyzere M; Duprez D Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720 [TBL] [Abstract][Full Text] [Related]
15. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B; JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161 [TBL] [Abstract][Full Text] [Related]
17. [Left ventricular hypertrophy; differences in diagnostic and prognostic value of electrocardiography and echocardiography]. Beltman FW Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2363-4. PubMed ID: 9550836 [No Abstract] [Full Text] [Related]
18. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy. Okin PM; Gerdts E; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B; Devereux RB; Hypertension; 2008 Jul; 52(1):100-6. PubMed ID: 18504323 [TBL] [Abstract][Full Text] [Related]